Addressing pancreatic health, Acute Pancreatitis companies focus on treatment solutions for this inflammatory condition. Through research and development, they offer therapeutic interventions that alleviate symptoms and improve outcomes for patients experiencing acute pancreatitis, contributing to advancements in gastroenterology and patient care.
Danaher Corporation (US) acquired the Biopharma business of GE Life Sciences, GE Healthcare, in 2020. This move solidified Danaher's position as a major player in the life sciences segment, including cell counting technologies.
Agilent Technologies acquired BioTek Instruments, Inc. (US) in 2019. This acquisition strengthens Agilent's portfolio of cell counting tools and instruments, particularly in the microplate reader segment.
PerkinElmer entered into an agreement with Accenture in 2019 to join their Open Partner Ecosystem Program. This collaboration focuses on leveraging technology and expertise to accelerate drug discovery and improve patient outcomes, which involves precise cell counting techniques.
Thermo Fisher Scientific launched the Countess™ III Automated Cell Counter in 2023. This new instrument offers advanced features like viability staining and cell size analysis, catering to various research and clinical applications.
Merck KGaA introduced the MilliporeSigma MobiCount™ Automated Cell Counter in 2022. This portable and handheld device provides rapid cell counting for point-of-care settings, expanding accessibility and convenience.
Logos Biosystems received US FDA 510(k) clearance for its Luna-II™ Automated Cell Counter in 2023. This innovative system utilizes fluorescence microscopy for high-resolution cell imaging and counting, further enhancing accuracy and versatility.
Acute Pancreatitis Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)